Cari Reed - Option Care Senior Services
| OPCH Stock | USD 35.42 0.99 2.88% |
Executive
Cari Reed is Senior Services of Option Care Health
| Address | 3000 Lakeside Drive, Bannockburn, IL, United States, 60015 |
| Phone | 312 940 2443 |
| Web | https://www.optioncarehealth.com |
Option Care Management Efficiency
The company has return on total asset (ROA) of 0.0603 % which means that it generated a profit of $0.0603 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1503 %, meaning that it created $0.1503 on every $100 dollars invested by stockholders. Option Care's management efficiency ratios could be used to measure how well Option Care manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Option Care's Return On Tangible Assets are increasing as compared to previous years. The Option Care's current Return On Assets is estimated to increase to 0.06, while Return On Capital Employed is projected to decrease to 0.07. As of now, Option Care's Other Current Assets are increasing as compared to previous years. The Option Care's current Total Current Assets is estimated to increase to about 1.6 B, while Intangible Assets are projected to decrease to under 18.6 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Christine Blodgett | Immunovant | N/A | |
| Alice Givens | Indivior PLC Ordinary | 52 | |
| Chris Potochar | Oscar Health | N/A | |
| Lalith Vadlamannati | Hinge Health | N/A | |
| Rebecca Krouse | Oscar Health | N/A | |
| Joel JD | Oscar Health | 79 | |
| Bianca Buck | Hinge Health | N/A | |
| John Hafl | ADMA Biologics | N/A | |
| Drew Pantello | ADMA Biologics | N/A | |
| Kimberly Brown | Lantheus Holdings | 36 | |
| Kathryn Hudson | Indivior PLC Ordinary | N/A | |
| Andy MBA | Immunovant | N/A | |
| Amanda Morgan | Lantheus Holdings | 47 | |
| Chelsea Cooper | Oscar Health | N/A | |
| Parag PharmD | ACADIA Pharmaceuticals | N/A | |
| JD Esq | Kymera Therapeutics | 66 | |
| Nick Corcoran | TransMedics Group | 42 | |
| Albert Kildani | ACADIA Pharmaceuticals | N/A | |
| Stephanie Kim | ACADIA Pharmaceuticals | N/A | |
| Lee Howe | Lantheus Holdings | N/A | |
| Jeffrey MD | Hinge Health | N/A | |
Management Performance
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0603 |
Option Care Health Leadership Team
Elected by the shareholders, the Option Care's board of directors comprises two types of representatives: Option Care inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Option. The board's role is to monitor Option Care's management team and ensure that shareholders' interests are well served. Option Care's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Option Care's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jill Rhodes, Senior Officer | ||
| Meenal CPA, Executive CFO | ||
| Kim Harvey, Senior Operations | ||
| John Rademacher, President CEO | ||
| Alyssa Moy, Chief Officer | ||
| Chris Grashoff, Chief Officer | ||
| Brett Michalak, Chief Officer | ||
| Eric Daugherty, Senior Programs | ||
| Luke Whitworth, Chief Officer | ||
| Michael Bavaro, Chief Officer | ||
| Maritza DeGagne, Senior Operations | ||
| Julie Koenig, Senior Operations | ||
| Mike Bavaro, Chief Officer | ||
| Femi MD, Chief Officer | ||
| Nicole Maggio, Principal Officer | ||
| Jorge Ramirez, Senior Development | ||
| Cari Reed, Senior Services | ||
| Christopher Hartman, Chief Officer | ||
| Ashley Mikles, Senior Contracting | ||
| Richard Denness, NonExecutive Employee | ||
| Collin Smyser, General Secretary | ||
| Benson Yang, Senior Development | ||
| Caroline Budde, Senior Officer | ||
| Stacey Mahone, Senior Officer | ||
| Michael Shapiro, Strategic Advisor | ||
| Roman Fry, Senior Development | ||
| Matthew Deans, Sr Devel | ||
| Christopher Grashoff, Chief Officer |
Option Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Option Care a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0603 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 6.43 B | ||||
| Shares Outstanding | 158.73 M | ||||
| Shares Owned By Insiders | 0.80 % | ||||
| Shares Owned By Institutions | 99.20 % | ||||
| Number Of Shares Shorted | 8.73 M | ||||
| Price To Earning | 64.68 X |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Option Care Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is there potential for Health Care Providers & Services market expansion? Will Option introduce new products? Factors like these will boost the valuation of Option Care. Anticipated expansion of Option directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Option Care listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.032 | Earnings Share 1.26 | Revenue Per Share | Quarterly Revenue Growth 0.122 | Return On Assets |
Understanding Option Care Health requires distinguishing between market price and book value, where the latter reflects Option's accounting equity. The concept of intrinsic value - what Option Care's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Option Care's price substantially above or below its fundamental value.
It's important to distinguish between Option Care's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Option Care should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Option Care's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.